LNCDAT
gene geneOn this page
Also known as YYLNCT
Summary
LNCDAT (lncRNA divergent activator of TBXT, HGNC:54855) is a long non-coding RNA gene on chromosome 6q27.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:54855 |
| Approved symbol | LNCDAT |
| Name | lncRNA divergent activator of TBXT |
| Location | 6q27 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | YYLNCT |
| Ensembl gene | ENSG00000288638 |
| Ensembl biotype | lncRNA |
| Entrez | 116804915 |
| RNAcentral | URS0001981274 — lncRNA, 1558 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000674611, ENST00000675059, ENST00000675188, ENST00000675446, ENST00000675788, ENST00000675895, ENST00000676186
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000674611 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003899253 | 166168014 | 166171172 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 52.68.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0821 / max 61.9758, expressed in 32 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 71152 | 0.0238 | 3 |
| 71156 | 0.0222 | 9 |
| 71153 | 0.0175 | 6 |
| 71155 | 0.0123 | 3 |
| 71154 | 0.0064 | 1 |
Top tissues by expression
52 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 52.68 | silver quality |
| prefrontal cortex | UBERON:0000451 | 51.92 | silver quality |
| pituitary gland | UBERON:0000007 | 51.19 | gold quality |
| brain | UBERON:0000955 | 50.65 | gold quality |
| blood | UBERON:0000178 | 50.47 | gold quality |
| lymph node | UBERON:0000029 | 50.38 | gold quality |
| tonsil | UBERON:0002372 | 49.05 | gold quality |
| adenohypophysis | UBERON:0002196 | 48.85 | gold quality |
| myometrium | UBERON:0001296 | 48.14 | silver quality |
| muscle of leg | UBERON:0001383 | 47.85 | gold quality |
| stomach | UBERON:0000945 | 47.68 | gold quality |
| vermiform appendix | UBERON:0001154 | 47.29 | silver quality |
| omental fat pad | UBERON:0010414 | 47.28 | gold quality |
| adipose tissue | UBERON:0001013 | 47.25 | gold quality |
| left coronary artery | UBERON:0001626 | 46.82 | gold quality |
| placenta | UBERON:0001987 | 45.83 | silver quality |
| gastrocnemius | UBERON:0001388 | 45.72 | silver quality |
| esophagus mucosa | UBERON:0002469 | 45.37 | gold quality |
| endometrium | UBERON:0001295 | 45.31 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 45.05 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 44.33 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 44.15 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 44.00 | gold quality |
| lower esophagus | UBERON:0013473 | 43.98 | gold quality |
| esophagus | UBERON:0001043 | 43.89 | gold quality |
| spleen | UBERON:0002106 | 43.68 | silver quality |
| right atrium auricular region | UBERON:0006631 | 43.42 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 43.31 | gold quality |
| tibial artery | UBERON:0007610 | 43.24 | silver quality |
| zone of skin | UBERON:0000014 | 43.21 | silver quality |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Signifying their developmental function, the key mesoderm specifier BRACHYURY (T) is accompanied by yylncT, which localizes to the active T locus during mesoderm commitment. (PMID:30554961)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.